Clinical Relevance of the Antimicrobial Resistance Testing in

Status Withdrawn

Clinical Trial Summary

The study objective is to improve the current and local standard antiseptic treatment by adjusting the antiseptic agent to the antimicrobial resistance testing result, accordingly. Currently, resistance testing will only be performed for the treatment with antibiotics.

Clinical Trial Description

Complications like bacterial wound colonization and infections in wound treatment are still a serious problem. Several therapy approaches are available to treat these complications, e.g. surgical wound debridement, antimicrobial therapy that can be divided into a local and a systemic antisepsis. The local antisepsis (the local utilization of antiseptics directly to the wound) is in many ways advantageous to the systemic antisepsis (orally or intravenously administered antibiotics): e. g. the direct contact of the antiseptic to the bacteria at the site of infection whereas antibiotics may not sufficiently reach the wound due to limited blood perfusion of wounds; growing utilization of systemic antisepsis also leads to an increasing number of resistant bacteria worldwide. To the concerns of many specialists, the first pan-resistant bacterial strain which is resistant to all available antibiotics including colistin was recently published. In future, the role of local antisepsis therefore becomes more important in the antimicrobial treatment. Luckily, resistances of local antiseptics occur slowly due to the chemical and structural characteristics of antiseptics but even resistances of bacteria to antiseptics were reported. Unlike the antimicrobial resistance testing for antibiotics that is done in the clinical routine, such testing is not a standard procedure for antiseptics for no obvious reason. The utilization of antiseptics is determined by the availability of products provided within the institution and preferences of the clinician. Thus, it is unknown whether the chosen antiseptic has any bactericidal effect on the confirmed bacteria. University Hospital RWTH Aachen Wound Care only uses polyhexanide and octenisept. Iodine-containing preparations are explicitly not desired.Improvement (bacteria reduction, acceleration of wound healing) of the local antiseptic therapy by adapting the antiseptic to the results of antimicrobial resistance testing. Antimicrobial resistance testing has so far only been used to adapt systemic antibiotic therapy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04172363
Study type	Interventional
Source	RWTH Aachen University
Contact
Status	Withdrawn
Phase	Phase 3
Start date	July 22, 2020
Completion date	May 22, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01442103` - Clinical Utility of a New Silver Gel for Use on Chronic Wounds	N/A
Completed	`NCT00425178` - FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers	Phase 1
Not yet recruiting	`NCT04411264` - Evaluation of the Effect of Virtual Reality on Pain in the Management of Chronic Wounds.	N/A
Recruiting	`NCT03882983` - Stromal Vascular Fraction From Lipoaspirate to Treatment of Chronic Non-healing Wound	Phase 1
Completed	`NCT04903366` - Absorption and Safety of Topical Timolol to Treat Chronic Wounds
Not yet recruiting	`NCT05491291` - Chronic Wound Care of Lower Limb in M@diCICAT Center at CHU de Martinique	N/A
Completed	`NCT01572376` - Autologous Bone Marrow Stem Cells in Pressure Ulcer Treatment	Phase 1/Phase 2
Completed	`NCT02053337` - A RCT to Compare Performance of Two Foam Dressings on Patient Well-being Related Endpoints.	N/A
Completed	`NCT02519166` - Characterisation of Biofilm of the Chronic Wounds	N/A
Completed	`NCT04320628` - Randomized Double-Blind Controlled Clinical Trial	N/A
Completed	`NCT04342767` - The Effectiveness of a Mechanical Debridement Instrument in Reducing Bioburden in Chronic Wounds
Not yet recruiting	`NCT06306716` - Single Center Clinical Study on New Negative Pressure Wound Therapy Dressing in the Management of Chronic & Acute Wounds
Not yet recruiting	`NCT05493943` - P.E.M.F. Therapy of Chronic Wounds	N/A
Completed	`NCT01881815` - Swab Sample Collection for the Detection of Bacterial Proteases	N/A
Completed	`NCT05764226` - Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for the Treatment of Chronic Wounds	N/A
Completed	`NCT03678636` - WOUNDCHEK Bacterial Status Benefits Evaluation	N/A
Terminated	`NCT03198169` - A Study to Investigate Two Atteris Antimicrobial Products on Chronic Wound Healing.	N/A
Not yet recruiting	`NCT05187676` - Clinical Evaluation of an Innovative Non-contact Optical Device for Skin Oxygenation Imaging	N/A
Recruiting	`NCT00535548` - Hematopoietic Stem Cell Therapy in Chronic Wounds Using a Pressure Sore Model	Phase 1
Active, not recruiting	`NCT03793062` - Genetic and Epigenetic Basis of Chronic Wounds

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Relevance of the Antimicrobial Resistance Testing in the Treatment of Chronic Wounds With Antiseptics — AntiSeptic

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms